Zurich Cantonal Bank
ALLO icon

Zurich Cantonal Bank’s Allogene Therapeutics ALLO Stock Holding History

Zurich Cantonal Bank’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-37,983
Closed -$80.9K – 2628
2024
Q4 		$80.9K Buy
37,983
+15,432
+68% +$38.1K ﹤0.01% 2493
2024
Q3 		$63.1K Hold
22,551
– – ﹤0.01% 2526
2024
Q2 		$52.5K Hold
22,551
– – ﹤0.01% 2532
2024
Q1 		$101K Hold
22,551
– – ﹤0.01% 2395
2023
Q4 		$72.4K Buy
22,551
+8,037
+55% +$22.8K ﹤0.01% 2537
2023
Q3 		$46K Hold
14,514
– – ﹤0.01% 2617
2023
Q2 		$72.1K Hold
14,514
– – ﹤0.01% 2495
2023
Q1 		$71.7K Hold
14,514
– – ﹤0.01% 2461
2022
Q4 		$91.3K Buy
14,514
+2,928
+25% +$27.1K ﹤0.01% 2327
2022
Q3 		$125K Hold
11,586
– – ﹤0.01% 2050
2022
Q2 		$132K Hold
11,586
– – ﹤0.01% 2045
2022
Q1 		$106K Hold
11,586
– – ﹤0.01% 2257
2021
Q4 		$173K Buy
11,586
+2,784
+32% +$49.1K ﹤0.01% 2166
2021
Q3 		$226K Buy
8,802
+2,144
+32% +$50.9K ﹤0.01% 1839
2021
Q2 		$174K Hold
6,658
– – ﹤0.01% 1898
2021
Q1 		$235K Sell
6,658
-2,180
-25% -$73.5K ﹤0.01% 1694
2020
Q4 		$223K Buy
8,838
+2,677
+43% +$87.3K ﹤0.01% 1773
2020
Q3 		$232K Hold
6,161
– – ﹤0.01% 1493
2020
Q2 		$264K Buy
6,161
+3,755
+156% +$136K ﹤0.01% 1350
2020
Q1 		$47K Hold
2,406
– – ﹤0.01% 1959
2019
Q4 		$63K Hold
2,406
– – ﹤0.01% 2007
2019
Q3 		$66K Hold
2,406
– – ﹤0.01% 1842
2019
Q2 		$65K Buy
+2,406
New +$67K ﹤0.01% 1891

Other funds holding ALLO

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Zurich Cantonal Bank's ALLO Position: Q1 2025 in Review

Zurich Cantonal Bank sold out of Allogene Therapeutics (ALLO) in Q1 2025, closing a stake of 37,983 shares — an estimated $80.9K sold.

Zurich Cantonal Bank first reported a position in ALLO in Q2 2019 and held it in 23 quarters. The position peaked at $264K in Q2 2020. 170 funds tracked by Wall St. Rank hold ALLO as of Q1 2025.

  • Zurich Cantonal Bank reported no remaining Allogene Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Zurich Cantonal Bank sold 37,983 Allogene Therapeutics shares in Q1 2025, an estimated $80.9K.
  • Zurich Cantonal Bank first reported a position in Allogene Therapeutics in Q2 2019 and held it in 23 quarters.
  • Zurich Cantonal Bank's Allogene Therapeutics position peaked at $264K in Q2 2020.
  • 170 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q1 2025.

Based on Zurich Cantonal Bank's 13F filing for Q1 2025, filed 7 May 2025.